The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...

AstraZeneca disclosed that a high-ranking executive who oversees international operations and is also president of its ...

IonQ aims to lead the quantum networking market with two key milestones achieved this year. Read more about IONQ stock here.

The jobs include roles in engineering and technical services and global supply chain functions. Read more at straitstimes.com ...

U.S. drugmakers and biotechs have come to rely on Chinese partners. Now, some of them are looking for alternatives as ...

AstraZeneca said its China president Leon Wang is under investigation and the drugmaker would cooperate with Chinese ...

H.C. Wainwright raised the firm’s price target on Monopar Therapeutics (MNPR) to $22 from $6 and keeps a Buy rating on the shares. The ...

BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” ...

Drug maker has yet to elaborate whether Leon Wang is in custody, nor have his whereabouts been disclosed AstraZeneca's China ...

At about 23 hectares, the site will mark AstraZeneca’s largest to date in terms of initial build investment. It is targeted to be operationally ready by 2029 to produce antibody drug conjugates (ADCs) ...

AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...

A subcutaneous version of Daiichi Sankyo’s AstraZeneca-partnered blockbuster antibody-drug conjugate (ADC) Enhertu could be ...